Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03066830
NCT03066830Phase 3Completed
- Sponsor
- Lexicon Pharmaceuticals, Inc.
- Start
- Feb 2017
- Primary completion
- Apr 2019
- Countries
- 10
01
Overview
Phase 3 trial, sponsored by Lexicon Pharmaceuticals, Inc. Started Feb 2017; status: completed.
Beyond the preview
Go deeper on NCT03066830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03066830.